ATC code N02Analgesicsis a therapeutic subgroup of theAnatomical Therapeutic Chemical Classification System,a system of alphanumeric codes developed by theWorld Health Organization(WHO) for the classification ofdrugsand other medical products.[1][2][3]Subgroup N02 is part of the anatomical groupNNervous system.[4]

Codes forveterinaryuse (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,QN02.[5]ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N02AA Natural opium alkaloids

edit
N02AA01Morphine
N02AA02Opium
N02AA03Hydromorphone
N02AA04Nicomorphine
N02AA05Oxycodone
N02AA08Dihydrocodeine
N02AA10Papaveretum
N02AA11Oxymorphone
N02AA51Morphine,combinations
N02AA53Hydromorphoneandnaloxone
N02AA55Oxycodoneandnaloxone
N02AA56Oxycodoneandnaltrexone
N02AA58Dihydrocodeine,combinations
N02AA59Codeine,combinations excludingpsycholeptics
N02AA79Codeine,combinations withpsycholeptics

N02ABPhenylpiperidinederivatives

edit
N02AB01Ketobemidone
N02AB02Pethidine
N02AB03Fentanyl
N02AB52Pethidine,combinations excludingpsycholeptics
QN02AB53Fentanyl,combinations excludingpsycholeptics
N02AB72Pethidine,combinations withpsycholeptics
QN02AB73Fentanyl,combinations withpsycholeptics
N02AC01Dextromoramide
N02AC03Piritramide
N02AC04Dextropropoxyphene
N02AC05Bezitramide
N02AC52Methadone,combinations excludingpsycholeptics
N02AC54Dextropropoxyphene,combinations excludingpsycholeptics
N02AC74Dextropropoxyphene,combinations withpsycholeptics
QN02AC90Methadone

N02ADBenzomorphanderivatives

edit
N02AD01Pentazocine
N02AD02Phenazocine
N02AD51 Pentazocine andnaloxone

N02AEOripavinederivatives

edit
N02AE01Buprenorphine
QN02AE90Etorphine
QN02AE99Oripavinederivatives, combinations

N02AFMorphinanderivatives

edit
N02AF01Butorphanol
N02AF02Nalbuphine

N02AG Opioids in combination withantispasmodics

edit
N02AG01Morphineandantispasmodics
N02AG02Ketobemidoneandantispasmodics
N02AG03Pethidineandantispasmodics
N02AG04Hydromorphoneandantispasmodics

N02AJ Opioids in combination with non-opioid analgesics

edit
N02AJ01Dihydrocodeineandparacetamol
N02AJ02Dihydrocodeineandacetylsalicylic acid
N02AJ03Dihydrocodeineand other non-opioidanalgesics
N02AJ06Codeineandparacetamol
N02AJ07Codeineandacetylsalicylic acid
N02AJ08Codeineandibuprofen
N02AJ09Codeineand other non-opioidanalgesics
N02AJ13Tramadol and paracetamol
N02AJ14Tramadolanddexketoprofen
N02AJ15Tramadoland other non-opioidanalgesics
N02AJ16Tramadol and celecoxib
N02AJ17Oxycodone and paracetamol
N02AJ18Oxycodone and acetylsalicylic acid
N02AJ19Oxycodone and ibuprofen
N02AJ22Hydrocodone and paracetamol
N02AJ23Hydrocodone and ibuprofen

N02AX Other opioids

edit
N02AX01Tilidine
N02AX02Tramadol
N02AX03Dezocine
N02AX05Meptazinol
N02AX06Tapentadol
N02AX07Oliceridine
N02AX51 Tilidine and naloxone

N02B Other analgesics andantipyretics

edit

N02BASalicylic acidand derivatives

edit
N02BA01Acetylsalicylic acid
N02BA02Aloxiprin
N02BA03Choline salicylate
N02BA04Sodium salicylate
N02BA05Salicylamide
N02BA06Salsalate
N02BA07Ethenzamide
N02BA08Morpholine salicylate
N02BA09Dipyrocetyl
N02BA10Benorilate
N02BA11Diflunisal
N02BA12Potassium salicylate
N02BA14Guacetisal
N02BA15Carbasalate calcium
N02BA16Imidazole salicylate
N02BA51Acetylsalicylic acid,combinations excludingpsycholeptics
N02BA55Salicylamide,combinations excludingpsycholeptics
N02BA57Ethenzamide,combinations excludingpsycholeptics
N02BA59Dipyrocetyl,combinations excludingpsycholeptics
N02BA65 Carbasalate calcium combinations excludingpsycholeptics
N02BA67Magnesium salicylate,combinations excludingpsycholeptics
N02BA71Acetylsalicylic acid,combinations withpsycholeptics
N02BA75Salicylamide,combinations withpsycholeptics
N02BA77Ethenzamide,combinations withpsycholeptics
N02BA79Dipyrocetyl,combinations withpsycholeptics
N02BB01Phenazone
N02BB02Metamizole
N02BB03Aminophenazone
N02BB04Propyphenazone
N02BB05Nifenazone
N02BB51Phenazone,combinations excludingpsycholeptics
N02BB52Metamizole sodium,combinations excludingpsycholeptics
N02BB53Aminophenazone,combinations excludingpsycholeptics
N02BB54Propyphenazone,combinations excludingpsycholeptics
N02BB71Phenazone,combinations withpsycholeptics
N02BB72Metamizole sodium,combinations withpsycholeptics
N02BB73Aminophenazone,combinations withpsycholeptics
N02BB74Propyphenazone,combinations withpsycholeptics
N02BE01Paracetamol
N02BE03Phenacetin
N02BE04Bucetin
N02BE05Propacetamol
N02BE51Paracetamol,combinations excludingpsycholeptics
N02BE53Phenacetin,combinations excludingpsycholeptics
N02BE54Bucetin,combinations excludingpsycholeptics
N02BE71Paracetamol,combinations withpsycholeptics
N02BE73Phenacetin,combinations withpsycholeptics
N02BE74Bucetin,combinations withpsycholeptics

N02BF Gabapentinoids

edit
N02BF01Gabapentin
N02BF02Pregabalin
N02BF03Mirogabalin

N02BG Other analgesics and antipyretics

edit
N02BG02Rimazolium
N02BG03Glafenine
N02BG04Floctafenine
N02BG05Viminol
N02BG06Nefopam
N02BG07Flupirtine
N02BG08Ziconotide
N02BG09Methoxyflurane
N02BG10Cannabinoids(includesnabiximols)
N02BG12Tanezumab
QN02BG90Frunevetmab
QN02BG91Bedinvetmab

N02C Antimigrainepreparations

edit

N02CA Ergot alkaloids

edit
N02CA01Dihydroergotamine
N02CA02Ergotamine
N02CA04Methysergide
N02CA07Lisuride
N02CA51Dihydroergotamine,combinations
N02CA52Ergotamine,combinations excludingpsycholeptics
N02CA72Ergotamine,combinations withpsycholeptics

N02CB Corticosteroid derivatives

edit
N02CB01Flumedroxone
N02CC01Sumatriptan
N02CC02Naratriptan
N02CC03Zolmitriptan
N02CC04Rizatriptan
N02CC05Almotriptan
N02CC06Eletriptan
N02CC07Frovatriptan
N02CC08Lasmiditan
N02CC51Sumatriptan and naproxen
N02CD01Erenumab
N02CD02Galcanezumab
N02CD03Fremanezumab
N02CD04Ubrogepant
N02CD05Eptinezumab
N02CD06Rimegepant
N02CD07Atogepant
N02CD08Zavegepant

N02CX Other antimigraine preparations

edit
N02CX01Pizotifen
N02CX02Clonidine
N02CX03Iprazochrome
N02CX05Dimetotiazine
N02CX06Oxetorone

References

edit
  1. ^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis".National Institutes of Health.Retrieved1 February2020.
  2. ^World Health Organization."Anatomical Therapeutic Chemical (ATC) Classification".World Health Organization.Retrieved3 January2022.
  3. ^"Structure and principles".WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018.Retrieved3 January2022.
  4. ^"ATC/DDD Index 2022: code N02".WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^"ATCvet Index 2022: code QN02".WHO Collaborating Centre for Drug Statistics Methodology.